EUVIMEDEUVIMED entdecken
Crossref

Superior Capsular Reconstruction With Acellular Dermal Allograft Improves Midterm Clinical Outcomes but Is Associated With High Rates of Graft Failure and Progression of Cuff Tear Arthropathy

Daniel J Cognetti iD, Andrew J Sheean, J Michael Proffitt, Andres Rahal iD, Stephen S Burkhart, Robert U Hartzler

Arthroscopy · 2026

DOI: 10.1002/arj.70063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthroscopy, 2026. Verfasst von Daniel J Cognetti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Brooke Army Medical Center, San Antonio, Texas, U.S.A. Hauptthemen laut MEDLINE: Acellular Dermis, Arthroscopy, Rotator Cuff Tear Arthropathy, Rotator Cuff Injuries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Arthroscopy Association of North American.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the midterm clinical and radiographic outcomes of arthroscopic superior capsular reconstruction (SCR) using acellular human dermal allograft.

Methods

The study period was from December 2022 to May 2024. Patients were eligible if they underwent SCR with dermal allograft for operatively irreparable posterosuperior rotator cuff tears by a single surgeon between 2013 and 2017. Exclusion criteria included SCR used as augmentation to complete rotator cuff repair, conversion to arthroplasty, inability to consent/participate, and practice administrative dismissal. Enrolled patients completed patient‐reported outcomes, radiographs, and magnetic resonance imaging at a minimum of 5‐year follow‐up. Imaging was independently assessed by a musculoskeletal radiologist.

Results

Of 136 SCRs (132 patients), 33 were excluded (augmentation to complete repair (n = 21), revision to arthroplasty (n = 3)) and 44 were lost to follow‐up. Final analysis included 59 SCRs (57 with patient‐reported outcomes, 32 with complete imaging), with minimum 5‐year follow‐up (median 6 years (range: 5.0‐8.1)). Final American Shoulder and Elbow Surgeons (median 83 (interquartile range (IQR) 77, 93)) and Single Assessment Numeric Evaluation scores (median 85 (IQR 75, 95)) were improved compared with preoperative values (American Shoulder and Elbow Surgeons: 48 (IQR 35, 64) P < .001; Single Assessment Numeric Evaluation scores: 40 (IQR 21, 50), P < .001), with 81% and 91% of patients exceeding the minimum clinically important difference for the respective measures. Radiographs revealed 63% (n = 20) of patients were Hamada grade 4 at final follow‐up (preoperative: Hamada 1: 66% (n = 21); 2: 16% (n = 5); 3: 16% (n = 5); 4: 3% (n = 1)), with a decreased acromiohumeral interval (median 3.5 mm (IQR 2.0, 5.0) compared with preoperative values (6.2 mm (IQR 4.2, 7.5)). Major graft discontinuity (Hasegawa V) was observed in 66% (n = 21) of patients.

Conclusions

Arthroscopic SCR with acellular dermal allograft substantially improves patient‐reported outcomes at midterm follow‐up, with a low overall reoperation rate. However, structural deterioration, including decreased acromiohumeral distance and a high graft failure rate, suggests that SCR may not significantly alter the natural history of massive rotator cuff tears. Level of Evidence Level IV, retrospective case series.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acellular DermisArthroscopyRotator Cuff Tear ArthropathyRotator Cuff InjuriesPlastic Surgery ProceduresJoint CapsuleHumansFemaleMaleMiddle AgedAgedDisease ProgressionRetrospective StudiesPatient Reported Outcome MeasuresTreatment OutcomeAllograftsFollow-Up Studies

Autor:innen und Institutionen

  • Brooke Army Medical Center, San Antonio, Texas, U.S.A.
  • Uniformed Services University of the Health Sciences, Bethesda, Maryland, U.S.A.
  • United States Army Institute of Surgical Research, San Antonio, Texas, U.S.A.
  • The San Antonio Orthopedic Group, San Antonio, Texas, U.S.A.
  • Burkhart Research Institute for Orthopedics, San Antonio, Texas, U.S.A.

ORCID-Profile: Daniel J Cognetti, Andres Rahal

Förderung

  • Arthroscopy Association of North American

Zitieren

APA

Cognetti, D. J., Sheean, A. J., Proffitt, J. M., Rahal, A., Burkhart, S. S., & Hartzler, R. U. (2026). Superior Capsular Reconstruction With Acellular Dermal Allograft Improves Midterm Clinical Outcomes but Is Associated With High Rates of Graft Failure and Progression of Cuff Tear Arthropathy. Arthroscopy. https://doi.org/10.1002/arj.70063

Vancouver

Cognetti DJ, Sheean AJ, Proffitt JM, Rahal A, Burkhart SS, Hartzler RU. Superior Capsular Reconstruction With Acellular Dermal Allograft Improves Midterm Clinical Outcomes but Is Associated With High Rates of Graft Failure and Progression of Cuff Tear Arthropathy. Arthroscopy. 2026. doi:10.1002/arj.70063

BibTeX
@article{Cognetti2026,
  author = {Cognetti, Daniel J and Sheean, Andrew J and Proffitt, J Michael and Rahal, Andres and Burkhart, Stephen S and Hartzler, Robert U},
  title = {Superior Capsular Reconstruction With Acellular Dermal Allograft Improves Midterm Clinical Outcomes but Is Associated With High Rates of Graft Failure and Progression of Cuff Tear Arthropathy},
  journal = {Arthroscopy},
  year = {2026},
  doi = {10.1002/arj.70063}
}
Kostenlos starten →